Xtant Medical

Xtant Medical has evolved from its origins as a Montana-based tissue bank into a commercial-stage developer of a comprehensive spinal surgery portfolio, integrating advanced orthobiologics with complementary spinal implant systems. Its key strategic advantage is a vertically integrated model that controls the supply chain from donor tissue recovery through final product distribution, ensuring quality and traceability. The company aims to drive growth by commercializing synergistic biologic-implant solutions, such as its Fortilink®-TS system with Tetrafuse® 3D technology, within the expansive global spinal fusion market.

Vertically integrated platform combining proprietary tissue processing for orthobiologics (DBM, viable cells, growth factors) with spinal implant design featuring 3D-printed porous titanium (Tetrafuse®) technology to create synergistic biologic-implant solutions.

Xtant competes against giants like Medtronic and Stryker by leveraging vertical integration, a focused synergistic product strategy, and a mission-driven ethos. Its success depends on executing this differentiated model effectively against competitors' vast sales and marketing resources.